Pyridine derivatives
The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts and solvates thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds for the treatment of pain.
1. A compound of the formula:
or a pharmaceutically acceptable salt or solvate thereof, wherein:
R 1 is (C 1 -C 6 )alkyl optionally substituted with Het 1 , Het 2 or (C 3 -C 7 )cycloalkyl, wherein said Het 1 , Het 2 and (C 3 -C 7 )cycloalkyl are optionally substituted on a ring carbon atom by one or more substituents each independently selected from (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy and halo(C 1 -C 4 )alkyl;
each R 2 is independently selected from fluoro, chloro, bromo and iodo;
n is 1, 2 or 3;
Het 1 is a 5- or 6-membered saturated or partially unsaturated heterocyclic group comprising one or two heteroatom ring members each independently selected from nitrogen, oxygen and sulphur, said ring nitrogen atom optionally bearing a (C 1 -C 4 )alkyl substituent and said ring sulphur atom optionally bearing 1 or 2 oxygen atoms; and
Het 2 is a 5- or 6-membered heteroaryl group comprising either (a) from 1 to 4 nitrogen atoms or (b) one oxygen or one sulphur atom and 0, 1 or 2 nitrogen atoms.
2. A compound according to claim 1 , wherein each R 2 is chloro.
3. A compound according to claim 1 or claim 2 , wherein n is 3.
4. A compound according to claim 3 , wherein the R 2 groups are in the 2, 3 and 5-positions on the phenyl, ring.
5. A compound according to any one of claims 1 to 4 , wherein R 1 is (C 1 -C 6 )alkyl, optionally substituted with piperidinyl, imidazolyl, morpholinyl, piperazinyl or pyrrolidinyl.
6. A pharmaceutical composition including a compound of the formula (I) or a pharmaceutically acceptable salt or solvate thereof, according to claim 1 , together with one or more pharmaceutically acceptable excipients.